A New Advancement in the Treatment of Presbyopia
On October 28, 2021, Allergan (an AbbVie Company), announced that the FDA approved a new treatment for Presbyopia – the Vuity eye drop. Vuity (pilocarpine HCl ophthalmic solution 1.25%) is the first ever FDA approved eye drop designed to treat age-related changes in vision caused by a gradual loss of elasticity in the lens of…
Read MoreThe KAMRA Inlay: Make Your Reading Glasses a Thing of the Past
If you love reading, you may find that as you get older, it gets harder and harder to do. You may find yourself holding your books far away from your face just to get them in focus. Don’t forget how annoying it is when you need to read something, but you can’t find your reading…
Read MoreFrantz EyeCare First in South Florida to Offer an Advanced Solution to Reading Glasses
Eye Procedure Restores Near Vision and Reduces Dependence on Reading Glasses It is estimated that nearly 114 million people in the United States are struggling with the frustratingly natural eye condition called presbyopia. Typically occurring in those over 40, presbyopia reduces the ability of the eye to focus on near objects, causing blurry reading vision….
Read MoreAge-related focus dysfunction: the new presbyopia
Language, especially medical terminology, can act as a barrier to patient understanding. Presbyopia is such a term. Despite the fact that millions of Americans are presbyopes, many will simply say they have “short arms syndrome” and dismiss the condition as a normal part of aging that is simply to be accepted not knowing there are…
Read More